Filing Details

Accession Number:
0001209191-23-050432
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-22 19:34:33
Reporting Period:
2023-09-22
Accepted Time:
2023-09-22 19:34:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1782223 Pyxis Oncology Inc. PYXS Pharmaceutical Preparations (2834) 831160910
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796310 Ann Pamela Connealy C/O Pyxis Oncology, Inc.
321 Harrison Avenue
Boston MA 02118
Cfo And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-22 5,000 $1.74 792,106 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Reporting Person purchased all 5,000 shares of common stock in the open market at a price of $1.739 per share.